Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 | P03372 | 1/20 | 0.52 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.47 |
| ▸ | KIF11 | P52732 | 2/20 | 0.44 |
| ▸ | BACE1 | P56817 | 1/20 | 0.42 |
| ▸ | TNKS | O95271 | 1/20 | 0.42 |
| ▸ | WNT3A | P56704 | 1/20 | 0.42 |
| ▸ | TNKS2 | Q9H2K2 | 1/20 | 0.42 |
| ▸ | F7 | P08709 | 1/20 | 0.42 |
| ▸ | F3 | P13726 | 1/20 | 0.42 |
| ▸ | MYC | P01106 | 1/20 | 0.41 |
| ▸ | MAX | P61244 | 1/20 | 0.41 |
| ▸ | NPBWR1 | P48145 | 1/20 | 0.41 |
| ▸ | ABCG2 | Q9UNQ0 | 4/20 | 0.41 |
| ▸ | C1R | P00736 | 1/20 | 0.40 |
| ▸ | CTSD | P07339 | 1/20 | 0.40 |
| ▸ | APP | P05067 | 1/20 | 0.40 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.40 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14951899 | 0.83 | ESR1 (0.52) | ESR1KDM4EKIF11BACE1TNKS | |
| Acridone SCHEMBL345058 | 0.80 | ALDH1A1 (0.54) | ESR1KDM4EMYCMAX | |
| Acridone SCHEMBL429571 | 0.80 | ALDH1A1 (0.54) | ESR1KDM4EMYCMAX | |
| Acridone SCHEMBL243819 | 0.78 | KDM4E (0.56) | KDM4EMYCMAX | |
| SCHEMBL13641613 | 0.76 | KDM4E (0.63) | ESR1KDM4EBACE1NPBWR1 | |
| SCHEMBL13894566 | 0.76 | CSNK2A2 (0.41) | ESR1KDM4EF7F3C1R | |
| Acridone SCHEMBL27574706 | 0.75 | KDM4E (0.54) | KDM4EMYCMAX | |
| Acridone SCHEMBL5719993 | 0.75 | KDM4E (0.54) | KDM4EMYCMAX | |
| Acridone SCHEMBL10800711 | 0.75 | KDM4E (0.54) | KDM4EMYCMAX | |
| SCHEMBL8574110 | 0.74 | DHODH (0.49) | KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2915576-B1 | EXTRACTING AGENT FOR SEPARATING LITHIUM ISOTOPES AND USE THEREOF | SHANGHAI INST ORGANIC CHEMISTRY CAS (CN) | 2019-07-03 | — | — | EP | disclosed |
| US-9963760-B2 | Backflow cascade novel process for producing lithium-7 isotope | SHANGHAI INSTITUTE OF ORGANIC CHEMISTRY, CHINESE ACADEMY OF SCIENCES (CN) | 2018-05-08 | — | — | US | disclosed |
| US-9926618-B2 | Extracting agent for separating lithium isotopes and use thereof | SHANGHAI INSTITUTE OF ORGANIC CHEMISTRY, CHINESE ACADEMY OF SCIENCES (CN) | 2018-03-27 | — | — | US | disclosed |
| US-20160215363-A1 | BACKFLOW CASCADE NOVEL PROCESS FOR PRODUCING LITHIUM-7 ISOTOPE | SHANGHAI INSTITUTE OF ORGANIC CHEMISTRY, CHINESE ACADEMY OF SCIENCES (CN) | 2016-07-28 | — | — | US | disclosed |
| US-20150299822-A1 | EXTRACTING AGENT FOR SEPARATING LITHIUM ISOTOPES AND USE THEREOF | SHANGHAI INSTITUTE OF ORGANIC CHEMISTRY, CHINESE ACADEMY OF SCIENCES (CN) | 2015-10-22 | — | — | US | disclosed |
| EP-2915576-A1 | EXTRACTING AGENT FOR SEPARATING LITHIUM ISOTOPES AND USE THEREOF | Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences (CN) | 2015-09-09 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150299822-A1 | EXTRACTING AGENT FOR SEPARATING LITHIUM ISOTOPES AND USE THEREOF | TCF7L2, LUC7L2, CDK7 | ESR1 695/4885KDM4E 437/4885KIF11 722/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.